Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background Intravenous naloxone frequently ameliorates the pruritus of cholestasis, but its low oral bioavailability precludes its use as a long-term therapy. Nalmefene is an orally bioavailable opiate antagonist. Objective We assessed the efficacy of oral nalmefene in ameliorating the pruritus of cholestasis. Methods In a prospective controlled study conducted in a tertiary referral hospital, 11 patients with generalized pruritus complicating chronic liver disease were randomized to receive either nalmefene or placebo in a double-blinded fashion for 2-month periods. Scratching activity was measured continuously for 24-hour periods at baseline and at the end of each treatment period. Results Data on 8 patients who received at least 1 course of nalmefene were available for comparison with corresponding control data, which consisted of observations obtained during a course of placebo and/or at baseline. Nalmefene therapy was associated with a 75% reduction in the geometric mean hourly scratching activity (P Conclusion Oral administration of nalmefene can ameliorate pruritus complicating chronic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Bergasa, N. V., Alling, D. W., Talbot, T. L., Swain, M. G., Yurdaydin, C., Turner, M. L., Schmitt, J. M., Walker, E. C., & Jones, E. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-3-199508010-00001 · Cited by 365
Self-citationOral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study
Wolfhagen, F., Sternieri, E., Hop, W., Vitale, G., Bertolotti, M., & Van Buuren, H. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322521 · Cited by 343
Opioid peptides and primary biliary cirrhosis
Thornton, J. R., & Losowsky, M. S. (1988) · BMJ · doi:10.1136/bmj.297.6662.1501 · Cited by 300
Stress-Induced Eating Is Mediated Through Endogenous Opiates
Morley, J. E., & Levine, A. S. (1980) · Science · doi:10.1126/science.6250222 · Cited by 295
A controlled trial of naloxone infusions for the pruritus of chronic cholestasis
Bergasa, N. V., Talbot, T. L., Alling, D. W., Schmitt, J. M., Walker, E. C., Baker, B. L., Korenman, J. C., Park, Y., Hoofnagle, J. H., & Jones, E. A. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90102-5 · Cited by 287
Self-citationOpen‐label trial of oral nalmefene therapy for the pruritus of cholestasis
Bergasa, N. V., Schmitt, J. M., Talbot, T. L., Alling, D. W., Swain, M. G., Turner, M. L., Jenkins, J. B., & Jones, A. E. (1998) · Hepatology · doi:10.1002/hep.510270307 · Cited by 182
Self-citationThe pruritus of cholestasis: Potential pathogenic and therapeutic implications of opioids
Bergasa, N. V., & Jones, E. A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90709-2 · Cited by 124
Self-citationCholestasis in the male rat is associated with naloxone-reversible antinociception
Bergasa, N. V., Alling, D. W., Vergalla, J., & Jones, E. A. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80471-4 · Cited by 109
Self-citationBinding of a new opiate antagonist, nalmefene, to rat brain membranes.
Me, M., Bolger, G. T., & Weissman, B. A. (1985) · PubMed · Cited by 106
Nalmefene: Intravenous safety and kinetics of a new opioid antagonist
Dixon, R., Howes, J., Gentile, J., Hsu, H.-B., Hsiao, J., Garg, D., Weidler, D., Meyer, M., & Tuttle, R. (1986) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1986.9 · Cited by 98
Cited by
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Self-citationLindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
“Patients with high opioidergic tone may experience an opiate withdrawal-like reaction to opioid antagonists, characterized by abdominal pain, high blood pressure, tachycardia, goose bumps, nightmares, and depersonalization.(201-204) To mitigate this effect, the dosage should be gradually introduced.”
BackgroundItch: scratching more than the surface
Twycross, R. (2003) · QJM · doi:10.1093/qjmed/hcg002 · Cited by 407
European S2k Guideline on Chronic Pruritus
Weisshaar, E., Szepietowski, J., Dalgard, F., Garcovich, S., Gieler, U., Giménez-Arnau, A., Lambert, J., Leslie, T., Mettang, T., Misery, L., et al. (2019) · Acta Dermato Venereologica · doi:10.2340/00015555-3164 · Cited by 405
Metadata
- Authors
- Bergasa, N. V., Alling, D. W., Talbot, T. L., Wells, M. C., & Jones, E. A.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Talbot, Thomas L.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 1999-09
- Volume
- 41
- Issue
- 3
- Pages
- 431-434
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2059876429
- Cited by
- 163
- References
- 18
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 6 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 7 · 2012: 5
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of the American Academy of Dermatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- nalmefene, chronic liver disease, scratching behavior, opioid antagonists, oral bioavailability
- MeSH terms
- Administration, Oral, Adult, Antipruritics, Cholestasis, Double-Blind Method, Humans, Naltrexone, Narcotic Antagonists, Pain Measurement, Pruritus, Tablets, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study. https://app.cochat.ai/papers/10.1016/s0190-9622(99)70117-9
- The paper
- Bergasa, N. V., Alling, D. W., Talbot, T. L., Wells, M. C., & Jones, E. A. (1999). Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/s0190-9622(99)70117-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.